Author

O. Bardhan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

A. E. Baxter· 1 shared A. E. Connolly-Sporing· 1 shared A. Kang· 1 shared A. Sulpizio· 1 shared B. Kokona· 1 shared C. A. Daly· 1 shared C. E. W. Crawford· 1 shared C. H. Londergan· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. E. Baxter

Author profile →

2 papers

Recent·Most cited

The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state and its deletion improves checkpoint blockade

S. E. McClory, O. Bardhan, K. S. Rome, J. R. Giles, A. E. Baxter, L. Xu, P. A. Gimotty, R. B. Faryabi, E. J. Wherry, W. S. Pear, M. S. Jordan

This study shows that deleting Trib1 shifts exhausted T cells to a KLR+ CD8+ effector state, enhancing viral clearance and checkpoint inhibitor response.

bioRxiv · Feb 16, 2023Immunology

Engineered chimeras unveil swappable modular features of fatty acid and polyketide synthase acyl carrier proteins

Y. I. Cho, C. L. Armstrong, A. Sulpizio, K. K. Acheampong, K. N. Banks, O. Bardhan, S. J. Churchill, A. E. Connolly-Sporing, C. E. W. Crawford, P. L. Cruz Parrilla, S. M. Curtis, L. M. De La Ossa, S. C. Epstein, C. J. Farrehi, G. S. Hamrick, , L. K. Charkoudian

This study designs chimeric acyl carrier proteins to swap modular features between different ACPs, enabling compatibility with specific enzymes for synthetic pathway engineering.

bioRxiv · Dec 30, 2021Biochemistry